35.87 0.00 (0.00%)
After hours: 4:46PM EDT
|Bid||33.00 x 100|
|Ask||40.00 x 100|
|Day's Range||35.35 - 37.15|
|52 Week Range||18.90 - 50.90|
|PE Ratio (TTM)||27.59|
|Forward Dividend & Yield||0.80 (2.28%)|
|1y Target Est||N/A|
Join Dave Bartosiak at 1:00pm Central Time on Thursday, October 20th, to see his thoughts on Petmed Express (PETS) before they report earnings with real-time options insight.
Maybe you’ve heard: The technology industry is flush with cash. The Business Journal pulled the Securities and Exchange Commission filings for the region’s public technology companies to find the 2016 compensation packages of the highest-paid executives. In all, 23 executives from seven publicly traded tech firms took home total individual compensation ranging from $546,424 to more than $25 million.
Petmed Express Inc (NASDAQ: PETS ) was in freefall Thursday after competitor PetSmart announced online ordering, auto-refills and home delivery for veterinary prescriptions, over-the-counter medications ...
PetMed is striving to implement several strategies to revitalize its top line. Yet a highly competitive market poses threats.
We've identified several stocks that investors should consider buying on the dip right now. All of these stocks have slumped a bit over the past four weeks, but their fortunes could be poised to change soon, as they are all currently sporting a Zacks Rank #1 (Strong Buy).
PetMed Express Inc (NASDAQ:PETS) is currently trading at a trailing P/E of 28.1x, which is lower than the industry average of 192.8x. Although some investors may jump to the conclusionRead More...
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing PetMed Express, Inc. with the following peers – Rite Aid Corporation, PharMerica Corporation, CVS Health Corporation, Walgreens Boots Alliance Inc and China Jo-Jo Drugstores, Inc. (RAD-US, PMC-US, CVS-US, WBA-US and CJJD-US). Dividend Quality Overview Over the last twelve months (prior to June 30, 2017), PETS-US ... Read more (Read more...)
The veterinary medicine e-tailer has a lot to prove to investors after a compelling short-seller report accused it of selling opioid drugs for pets in a way that encouraged their abuse by human addicts.
Phibro Animal (PAHC) reported solid fourth-quarter fiscal 2017 revenues on the back of sales growth in the Animal Health, Mineral Nutrition and Performance Products segments.
Lantheus Holdings (LNTH) banks on DEFINITY and TechneLite sales for growth. The company's focus on global expansion is also encouraging.
Amazon.com Inc. (AMZN) is constantly expanding its video content and increasing its Prime members to further penetrate the streaming market.
PetMed Express (PETS:US), an online pet pharmacy, had a tumultuous past week, dropping as much as 15% intraday Thursday under heavy volume from its peak. This volatility is the result of allegations published in a bombshell report by research firm Aurelius Value.
PetMed Express (PETS) focuses on advertising to boost new order sales is striving to implement several strategies to revitalize its top line.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to PetMed Express, Inc. Here are 5 ETFs with the largest exposure to PETS-US. Comparing the performance and risk of PetMed Express, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
The corporate skirmish comes at a time of renewed attention to the possibility of pet opioid abuse.
A seller of pet drugs has requested its painkiller ads be removed from Google search results after a short seller said addicts were seeing them when searching for drugs online.
Alphabet Inc (NASDAQ:GOOG,NASDAQ:GOOGL) shares fell as the company got in trouble following Petmed Express Inc’s (NASDAQ:PETS) Tramadol ads. The tech giant announced that it would be removing its Tramadol ads from Petmed over allegations that the painkiller was being marketed to humans. Google is likely trying to distance itself from being a part of the growing opioid epidemic that has hit the nation in recent years.
PetMed (PETS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.